Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPolynovo Ltd

Polynovo Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.89 AUD -0.01 ( 1.66%)
Last update at 2026-11-06T05:10:00Z
VOLUME
993408
Market Cap
625.21M
P/E
90.50

Momentum Score

…

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.88
Low
0.91
High
52 Week Price Range
0.81
Low
1.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Polynovo Ltd is an Australian medical technology company that develops and commercializes biodegradable polymer products for wound care and surgical applications, including the NovoSorb biodegradable temporizing matrix. Long-term growth drivers include international regulatory approvals, commercial roll-out in the US and Europe, additional product introductions and wider clinical adoption that could support recurring revenue.

Material investment risks include execution and commercial adoption challenges, regulatory and reimbursement setbacks, concentration in a limited product portfolio and markets, and uncertainty about achieving sustained profitability and cash generation.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.91
Dividend Yield
-
Revenue TTM
149.85M
Revenue Per Share
0.22
Gross Profit TTM
129.28M
Debt / Equity
0.21
ROE
8.44%
Net Debt
-30.53M
ROCE
9.74%
Diluted EPS TTM
0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 7.82M 7.52M 1.71M -4.93M -1.15M
Net income 7.34M 13.21M 5.26M -4.92M -1.19M
Selling general administrative 103.72M 94.12M 75.26M 50.84M 28.58M
Selling and marketing expenses - 4.45M 3.29M 2.36M 1.26M
Gross profit 128.48M 122.05M 97.71M 60.81M 39.24M
Reconciled depreciation 2.69M 2.70M 2.19M 2.04M 1.59M
Ebit - 7.75M 1.85M -4.75M 0.54M
Ebitda - 10.45M 4.59M -2.71M 2.13M
Depreciation and amortization - 2.70M 2.74M 2.04M 1.59M
Operating income 10.47M 4.48M 1.16M -5.09M 0.54M
Other operating expenses - 122.76M 102.03M 47.03M 26.83M
Interest expense 0.25M 0.88M 0.72M 0.19M 0.32M
Tax provision 0.48M -5.70M -3.55M -0.01M 0.04M
Interest income 0.14M 0.49M 1.53M 0.87M 0.00M
Net interest income -0.79M -0.40M 0.81M 0.16M -0.31M
Income tax expense - -5.70M -3.55M -0.01M 0.04M
Total revenue 143.71M 127.24M 103.19M 65.24M 41.44M
Total operating expenses - 117.56M 34.92M 66.99M 39.49M
Cost of revenue 15.22M 5.20M 5.48M 4.43M 2.20M
Total other income expense net -1.86M 3.04M 0.55M 1.10M -0.58M
Net income from continuing ops 7.34M 13.21M 5.26M -4.92M -1.19M
Net income applicable to common shares - 13.21M 5.26M -4.92M -1.19M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 132.14M 127.41M 109.17M 92.62M 34.97M
Intangible assets 0.41M 0.66M 0.91M 1.16M 1.40M
Other current assets 1.59M 0.81M 3.30M 0.31M 0.15M
Total liab 41.44M 44.15M 37.04M 27.24M 17.26M
Total stockholder equity 90.70M 83.26M 72.12M 65.38M 17.72M
Deferred long term liab - - - 0.18M 0.33M
Other current liab - - 14.11M 9.93M 5.93M
Common stock - - 191.60M 191.59M 139.43M
Capital stock 191.76M 191.76M 191.60M 191.59M 139.43M
Retained earnings -95.56M -102.90M -116.12M -121.38M -116.45M
Other liab - - - 0.42M 0.29M
Other assets - - - 0.74M 0.63M
Cash 35.42M 33.53M 45.91M 46.85M 6.10M
Total current liabilities 24.69M 27.88M 23.25M 12.67M 7.76M
Current deferred revenue - - 0.21M -1.89M -1.83M
Net debt - - -30.53M -30.80M 4.89M
Short term debt - - 2.54M 1.89M 1.79M
Short long term debt 2.07M 1.50M 1.89M 1.40M 1.33M
Short long term debt total - - 15.38M 16.04M 10.99M
Other stockholder equity - - - -70.21M -22.98M
Property plant equipment - - - 23.37M 16.75M
Total current assets 73.88M 77.10M 79.30M 67.35M 16.19M
Long term investments 0.68M 0.66M 0.57M 0.56M 0.30M
Net tangible assets - - - 64.23M 16.31M
Short term investments 0.05M 0.05M 0.05M 0.05M 0.05M
Net receivables 21.02M 22.72M 21.07M 13.69M 6.09M
Long term debt 1.56M 2.22M 0.74M 1.79M 2.80M
Inventory 9.84M 14.49M 8.97M 4.53M 2.54M
Accounts payable 4.22M 6.94M 6.39M 2.74M 1.87M
Accumulated other comprehensive income - - -3.36M -4.83M -5.26M
Non currrent assets other - - 0.04M 0.18M 0.33M
Non current assets total 58.25M 50.31M 29.87M 25.27M 18.78M
Capital lease obligations 13.98M 13.42M 12.75M 12.86M 6.86M
Long term debt total - - - 14.15M 9.21M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -13.22M -1.49M -0.85M 5.86M
Change to liabilities - - - 4.17M -0.14M
Total cashflows from investing activities - -13.22M -1.49M -0.85M 5.86M
Net borrowings -3.69M -1.48M -2.65M -3.99M -5.57M
Total cash from financing activities -5.25M -2.39M -3.17M 48.06M -5.39M
Change to operating activities - - - 0.10M 0.80M
Net income 7.34M 13.21M 5.26M -4.92M -1.19M
Change in cash 4.20M -12.37M -0.94M 40.74M -1.59M
Begin period cash flow 33.53M 45.91M 46.85M 6.10M 7.69M
End period cash flow 35.42M 33.53M 45.91M 46.85M 6.10M
Total cash from operating activities - 3.15M 3.68M -6.61M -2.06M
Issuance of capital stock - - - 52.05M 0.18M
Depreciation - - 2.74M 2.28M 1.80M
Other cashflows from investing activities - 0.71M 1.41M 0.68M 0.00M
Change to inventory - -5.52M -4.49M -1.99M -0.58M
Change to account receivables - -3.32M -6.79M -7.43M -0.28M
Sale purchase of stock - - 0.00M 52.05M 0.18M
Other cashflows from financing activities - -0.91M -0.52M -0.83M 1.53M
Change to netincome - - - 1.18M -2.32M
Capital expenditures 13.80M 13.93M 2.90M 1.53M 0.49M
Change in working capital - -3.58M -9.91M -9.42M -0.85M
Stock based compensation - - 1.54M 1.11M -3.48M
Other non cash items - 6.73M 5.59M -3.97M -2.66M
Free cash flow 9.31M -10.78M 0.79M -8.14M -2.55M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PNV
Polynovo Ltd		 -0.01
1.66%		 0.89 90.50 90.91 4.17 6.67 4.08 54.57
COH
Cochlear Ltd		 1.03
0.67%		 155.47 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 -0.03
2.29%		 1.28 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 -0.36
4.21%		 8.20 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.08
1.73%		 4.55 - 9.97 9.59 7.17 6.76 15.37

Profile*

Polynovo Ltd

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

320 Lorimer Street, Port Melbourne, VIC, Australia, 3207

61 3 8681 4050

https://polynovo.com

301

Name Title Year Born
Mr. Jan-Marcel Gielen C.A. CFO & Company Sec. NA
Dr. David McQuillan Ph.D. Chief Technical & Scientific Officer NA
Mr. Swami Raote BPHARM, M.B.A. CEO & Director NA
Mr. Ahmed Hassan Director of Operations NA
Ms. Teena Chadha APAC Marketing & Distributor Mang. NA
Ms. Monica Benyk HR Mang. NA
Dr. Tim Moore Principal Scientist NA
Mr. Edward Graubart Sr. VP of Sales & Marketing (Americas) NA
Mr. Jan-Marcel Gielen C.A. CFO & Company Secretary NA
Mr. Philip Scorgie Chief Information Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…